Saanichton, BC

Dr. Miguel A. Lipka

Neuronal Migration Disorders

Neuronal migration disorders (NMDs) are a group of birth defects caused by the abnormal migration of neurons in the developing brain and nervous system.

In the developing brain, neurons must migrate from the areas where they are born to the areas where they will settle into their proper neural circuits. Neuronal migration, which occurs as early as the second month of gestation, is controlled by a complex assortment of chemical guides and signals. When these signals are absent or incorrect, neurons do not end up where they belong. This can result in structurally abnormal or missing areas of the brain in the cerebral hemispheres, cerebellum, brainstem, or hippocampus.

The structural abnormalities found in NMDs include:

  • Schizencephaly
  • Porencephaly
  • Lissencephaly
  • Agyria
  • Macrogyria
  • Pachygyria
  • Microgyria
  • Micropolygyria
  • Neuronal heterotopias (including band heterotopia)
  • Agenesis of the corpus callosum
  • Agenesis of the cranial nerves

Symptoms vary according to the abnormality, but often feature:

  • Poor muscle tone and motor function
  • Seizures
  • Developmental delays
  • Mental retardation
  • Failure to grow and thrive
  • Difficulties with feeding
  • Swelling in the extremities
  • A smaller than normal head

Most infants with an NMD appear normal, but some disorders have characteristic facial or skull features that can be recognized by a neurologist.

Several genetic abnormalities in children with NMDs have been identified. Defects in genes that are involved in neuronal migration have been associated with NMDs, but the role they play in the development of these disorders is not yet well-understood. More than 25 syndromes resulting from abnormal neuronal migration have been described. Among them are syndromes with several different patterns of inheritance; genetic counseling thus differs greatly between syndromes.

The prognosis for children with NMDs varies depending on the specific disorder and the degree of brain abnormality and subsequent neurological losses.

Treatment is symptomatic, and may include anti-seizure medication and special or supplemental education consisting of physical, occupational, and speech therapies.